David Rosmarin, MD, provides insights on vitiligo and its prevalence among the patient population.
Updates in the Treatment of Vitiligo
David Rosmarin, MD, illustrates the impacts of vitiligo on patient quality of life.
Dr Rosmarin gives a brief overview of treatment pathways.
Dr Rosmarin explores several treatment approaches for vitiligo, including specific options for oral repigmentation treatments.
JAK inhibitors’ effectiveness as a frontline treatment option for vitiligo is discussed by a key opinion leader in vitiligo treatment.
Dr Rosmarin describes the impacts of ruxolitinib on the treatment strategies for vitiligo.
Payer perspectives are considered for the treatment of vitiligo.
Dr Rosmarin navigates unmet needs and the trajectory of vitiligo treatment.
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
New pulmonary fibrosis drugs put guidelines in focus, Prusi says | AMCP Nexus 2026
2
Targeted therapies for atopic dermatitis reduce hospitalizations and ER visits, but cost is a different story
3
Fewer than half of newly diagnosed children with type 1 diabetes get autoantibody testing
4
FDA tentatively approves first generic lenacapavir for HIV prevention in lower-income countries
5